...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Great Presetation today

Actually that investment was in Zenith Epigenetics Inc and was prior to the reorg. As such the shares Eastern purchased are part of the ZCC share capital and will participate in any RPs dividends in the future.

Yes, my post is incorrect.

 

Share
New Message
Please login to post a reply